Oxygen, oxidative stress and anti oxidant supplementation, or an other way for nutrition in respiratory diseases;Oxygène, stress oxydant et supplémentations antioxydantes ou un aspect différent de la nutrition dans les maladies respiratoires

Nutrition Clinique et Metabolisme

Volumn 20, Issue 4, 2006, Pages 165-177

  Koechlin Ramonatxo, Christelle ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

Antioxidant treatment; Chronic obstructive pulmonary disease; Degenerative diseases; Health; Reactive oxygen species

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CYSTEINE; FLAVANOID; SELENIUM; ZINC;

ARTICLE; CELL METABOLISM; GENOMICS; HUMAN; OXIDATIVE STRESS; RESPIRATORY TRACT DISEASE; SURVIVAL;

EID: 33845382695     PISSN: 09850562     EISSN: 17683092     Source Type: Journal    
DOI: 10.1016/j.nupar.2006.10.178     Document Type: Article

References (133)

1. Lennie T.A. Nutritional recommendations for patients with heart failure. J. Cardiovasc. Nurs. 21 4 (2006) 261-268
2. Dwyer J. Starting down the right path: nutrition connections with chronic diseases of later life. Am. J. Clin. Nutr. 83 2 (2006) 415S-420S
3. SPLF. Guidelines for the clinical management of COPD. Oxygen therapy and long-term ventilatory assisatance. Rev. Mal. Respir. 20 (2003) S50-S53
4. Haliwell B., and Gutteridge J.M.C. Biology and Medecine (1989), Free Radicals in Claenton Prep, Oxford [543p]
5. Dekhuijzen P.N. Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease. Eur. Respir. J. 23 (2004) 629-636
6. Rahman I.I., and Kilty I. Antioxidant therapeutic targets in COPD. Curr. Drug Targets 7 (2006) 707-720
7. Leeuwenburgh C., and Heinecke J.W. Oxidative stress and antioxidants in exercise. Curr. Med. Chem. 8 (2001) 829-838
8. Asmus K.D., and Bonifacic M. Free radical chemistry. In: Sen C.K., Packer L., and Hanninen O. (Eds). Handbook of Oxidants and Antioxidants in Exercise (2000), Elsevier, Amsterdam 3-53
9. Ji L.L. Exercise at old age: does it increase or alleviate oxidative stress?. Ann. N. Y. Acad. Sci. 928 (2001) 236-247
10. Lander H.M. An essential role for free radicals and derived species in signal transduction. FASEB J. 11 (1997) 118-124
11. Powers S.K., Locke A.M., and Demirel H.A. Exercise, heat shock proteins, and myocardial protection from I-R injury. Med. Sci. Sports Exerc. 33 (2001) 386-392
12. Barouki R., and Morel Y. [Oxidative stress and gene expression]. J. Soc. Biol. 195 (2001) 377-382
13. Reid M.B., Khawli F.A., and Moody M.R. Reactive oxygen in skeletal muscle. III. Contractility of unfatigued muscle. J. Appl. Physiol. 75 (1993) 1081-1087
14. Balon T.W., and Nadler J.L. Nitric oxide release is present from incubated skeletal muscle preparations. J. Appl. Physiol. 77 (1994) 2519-2521
15. Macnee W., and Rahman I. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 160 (1999) S58-S65
16. Powers S.K., and Sen C.K. Physiological antioxidants and exercise training. In: Sen C.K., Packer L., and Hanninen O. (Eds). Handbook of Oxidants and Antioxidants in Exercise (2000), Elsevier, Amsterdam 221-241
17. Davies K.J. Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems. IUBMB Life 50 (2000) 279-289
18. Dean R.T., Fu S., Stocker, R, and Davies M.J. Biochemistry and pathology of radical-mediated protein oxidation. Biochem. J. 324 Pt 1 (1997) 1-18
19. Hartmann A., and Niess A.M. Oxidative DNA damage in exercise. In: Sen C.K., Packer L., and Hanninen O. (Eds). Handbook of Oxidants and Antioxidants in Exercise (2000), Elsevier, Amsterdam 195-217
20. Kondo H. Oxidative stress in muscular atrophy. In: Sen C.K., Packer L., and Hanninen O. (Eds). Handbook of Oxidants and Antioxidants in Exercise (2000), Elsevier, Amsterdam 631-653
21. Kondo H., Miura M., and Itokawa Y. Oxidative stress in skeletal muscle atrophied by immobilization. Acta Physiol. Scand. 142 (1991) 527-528
22. Davies K.J. Protein damage and degradation by oxygen radicals. I. general aspects. J. Biol. Chem. 262 (1987) 9895-9901
23. Gardner A.M., Xu F.H., Fady C., Jacoby F.J., Duffey D.C., Tu Y., et al. Apoptotic vs. nonapoptotic cytotoxicity induced by hydrogen peroxide. Free Radic. Biol. Med. 22 (1997) 73-83
24. McConkey D.J. Biochemical determinants of apoptosis and necrosis. Toxicol. Lett. 99 (1998) 157-168
25. Khawli F.A., and Reid M.B. N-acetylcysteine depresses contractile function and inhibits fatigue of diaphragm in vitro. J. Appl. Physiol. 77 (1994) 317-324
26. Novelli G.P., Bracciotti G., and Falsini S. Spin-trappers and vitamin E prolong endurance to muscle fatigue in mice. Free Radic. Biol. Med. 8 (1990) 9-13
27. Reid M.B. Muscle fatigue: mechanisms and regulation. In: Sen C.K., Packer L., and Hanninen O. (Eds). Handbook of Oxidants and Antioxidants in Exercise (2000), Elsevier, Amsterdam 599-629
28. Tretter L., and Adam-Vizi V. Inhibition of Krebs cycle enzymes by hydrogen peroxide: a key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J. Neurosci. 20 (2000) 8972-8979
29. Kang D., and Hamasaki N. Mitochondrial oxidative stress and mitochondrial DNA. Clin. Chem. Lab. Med. 41 (2003) 1281-1288
30. Droge W. Free radicals in the physiological control of cell function. Cellular Physiol. Rev. 82 (2002) 47
31. Lee K.W., and Lee H.J. Biphasic effects of dietary antioxidants on oxidative stress-mediated carcinogenesis. Mech. Ageing Dev. 127 5 (2006) 424-431
32. Klaunig J.E., and Kamendulis L.M. The role of oxidative stress in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 239-267
33. Hitchon C.A., and El-Gabalawy H.S. Oxidation in rheumatoid arthritis. Arthritis Res. Ther. 6 6 (2004) 265-278
34. Norris E.H., and Giasson B.I. Role of oxidative damage in protein aggregation associated with Parkinson's disease and related disorders. Antioxid Redox Signal 7 5-6 (2005) 672-684
35. Moreira P.L., Zhu X., Nunomura A., Smith M.A., and Perry G. Therapeutic opyions in Alzheimer's disease. Expert Rev. Neurother. 6 6 (2006) 897-910
36. Harman D. The free radical theory of aging. Antioxid. Redox Signal. 5 (2003) 557-561
37. Ray A.L., Semba R.D., Walston J., Ferruci L., Cappola A.R., Ricks M.O., et al. Low serum selenium and otal carotenoids predict mortality among older women living in the community: the women's health and aging studies. J. Nutr. 136 1 (2006) 172-176
38. Hercberg S., Galan P., Preziosi P., Bertrais S., Mennen L., Malvy D., et al. The SUVIMAX study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch. Intern. Med. 164 21 (2004) 2335-2342
39. Walda IC, Tabak C, Smit HA, Rasanen L, Fiadanza F, Menotti A, et al. Diet and 20-year chronic obstructive pulmonary disease mortality in middle-aged men from three European Countries.
40. Davies A.A., Davey S.G., Harbord R., Bekkering G.E., Sterne J.A., Beynon R., et al. Nutritional interventions and outcome in patients with cancer or preinvasive lesions: systematic review. J. Natl. Cancer Inst. 98 14 (2006) 961-973
41. Hodge W.G., Schachter H.M., Bares D., Pan Y., Lowcock E.C., Zhang L., et al. Efficacy of omega-3 fatty acids in preventing age-related macular degeneration: a systematic review. Opthalmology 113 7 (2006) 1165-1172
42. Coulter I.D., Hardy M.L., Morton S.C., Hilton L.G., Tu W., Valentine D., et al. Antioxidants vitamine C and vitamine E for the prenvention and treatment of cancer. J. Gen. Intern. Med. 21 7 (2006) 735-744
43. ATBC study. The effect of vitamine E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330 (1994) 1029-1035
44. Omenn G.S., Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Glass A., et al. Risk factor for lung cancer and for intervention effects in CARET, the beta-carotene and Retinol Efficacy Trial. J. Natl. Cancer Inst. 88 (1996) 1550-1559
45. Chan J.M., Stampfer M.J., Ma J., Rimm E.B., Wilett W.C., and Giovannuci E.L. Supplemental vitamine E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol. Biomarkers Prev. 8 (1999) 893-899
46. Schwartz JL. The dual roles of nutrients as antioxidants and prooxidants: their effect of tumor cell growth. J Nutr 1996;126(4 Suppl):1221S-7S.
47. Palozza P. Prooxidant actions of carotenoids in biologic systems. Nutr. Rev. 56 (1998) 257-265
48. Feenstra T.L., van Genugten M.L., Hoogenveen R.T., Wouters E.F., and Rutten-van Molken M.P. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am. J. Respir. Crit. Care Med. 164 (2001) 590-596
49. MacNee W. Oxidants/antioxidants and COPD. Chest 117 (2000) 303S-317S
50. Zang L.Y., Stone K., and Pryor W.A. Detection of free radicals in aqueous extracts of cigarette tar by electron spin resonance. Free Radic. Biol. Med. 19 (1995) 161-167
51. Oudijk E.J., Lammers J.W., and Koenderman L. Systemic inflammation in chronic obstructive pulmonary disease. Eur. Respir. J. Suppl. 46 (2003) 5s-13s
52. Gan W.Q., Man S.F., Senthilselvan A., and Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59 (2004) 574-580
53. Adamson G.M., and Billings R.E. The role of xanthine oxidase in oxidative damage caused by cytokines in cultured mouse hepatocytes. Life Sci. 55 (1994) 1701-1709
54. Sahnoun Z., Jamoussi K., and Zeghal K.M. Free radicals and antioxidants: physiology, human pathology and therapeutic aspects (part II). Therapie 53 (1998) 315-339
55. Reid M.B., and Li Y.P. Cytokines and oxidative signalling in skeletal muscle. Acta Physiol. Scand. 171 (2001) 225-232
56. Li Y.P., Atkins C.M., Sweatt J.D., and Reid M.B. Mitochondria mediate tumor necrosis factor-alpha/NF-kappaB signaling in skeletal muscle myotubes. Antioxid. Redox Signal. 1 (1999) 97-104
57. Richter C., Gogvadze V., Laffranchi R., Schlapbach R., Schweizer M., Suter M., et al. Oxidants in mitochondria: from physiology to diseases. Biochim. Biophys. Acta 1271 (1995) 67-74
58. Rahman I., Li X.Y., Donaldson K., Harrison D.J., and MacNee W. Glutathione homeostasis in alveolar epithelial cells in vitro and lung in vivo under oxidative stress. Am. J. Physiol. 269 (1995) L285-L292
59. Rahman I., and MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur. Respir. J. 16 (2000) 534-554
60. Dooley M.M., and Pryor W.A. Free radical pathology: inactivation of human alpha-1-proteinase inhibitor by products from the reaction of nitrogen dioxide with hydrogen peroxide and the etiology of emphysema. Biochem. Biophys. Res. Commun. 106 (1982) 981-987
61. Li Y.P., Schwartz R.J., Waddell I.D., Holloway B.R., and Reid M.B. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. FASEB J. 12 (1998) 871-880
62. Rahman I., Gilmour P.S., Jimenez L.A., and MacNee W. Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. Mol. Cell. Biochem. 234-235 (2002) 239-248
63. Emerit J., Klein J.M., Coutellier A., and Congy F. [Free radicals and lipid peroxidation in cell biology: physiopathologic prospects]. Pathol. Biol. (Paris) 39 (1991) 316-327
64. Clanton T.L., and Klawitter P.F. Invited review: adaptive responses of skeletal muscle to intermittent hypoxia: the known and the unknown. J. Appl. Physiol. 90 (2001) 2476-2487
65. Granger D.N., Hollwarth M.E., and Parks D.A. Ischemia-reperfusion injury: role of oxygen-derived free radicals. Acta Physiol. Scand. Suppl. 548 (1986) 47-63
66. Davies K.J., Quintanilha A.T., Brooks G.A., and Packer L. Free radicals and tissue damage produced by exercise. Biochem. Biophys. Res. Commun. 107 (1982) 1198-1205
67. Jackson M.J., Edwards R.H., and Symons M.C. Electron spin resonance studies of intact mammalian skeletal muscle. Biochim. Biophys. Acta 847 (1985) 185-190
68. Reid M.B., Shoji T., Moody M.R., and Entman M.L. Reactive oxygen in skeletal muscle. II. Extracellular release of free radicals. J. Appl. Physiol. 73 (1992) 1805-1809
69. Powers S.K., Ji L.L., and Leeuwenburgh C. Exercise training-induced alterations in skeletal muscle antioxidant capacity: a brief review. Med. Sci. Sports Exerc. 31 (1999) 987-997
70. Lawler J.M., Powers S.K., Visser T., Van Dijk H., Kordus M.J., and Ji L.L. Acute exercise and skeletal muscle antioxidant and metabolic enzymes: effects of fiber type and age. Am. J. Physiol. 265 (1993) R1344-R1350
71. Sastre J., Asensi M., Gasco E., Pallardo F.V., Ferrero J.A., Furukawa T., et al. Exhaustive physical exercise causes oxidation of glutathione status in blood: prevention by antioxidant administration. Am. J. Physiol. 263 (1992) R992-R995
72. Kanter M.M., Nolte L.A., and Holloszy J.O. Effects of an antioxidant vitamin mixture on lipid peroxidation at rest and postexercise. J. Appl. Physiol. 74 (1993) 965-969
73. Pinamonti S., Leis M., Barbieri A., Leoni D., Muzzoli M., Sostero S., et al. Detection of xanthine oxidase activity products by EPR and HPLC in bronchoalveolar lavage fluid from patients with chronic obstructive pulmonary disease. Free Radic. Biol. Med. 25 (1998) 771-779
74. Dekhuijzen P.N., Aben K.K., Dekker I., Aarts L.P., Wielders P.L., van Herwaarden C.L., et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 154 (1996) 813-816
75. Chanez P. Stress oxydatif dans Broncho-pneumopathie chronique obstructive (2003), Eds Margaux Orange, Paris 129-144
76. Heunks L.M., Vina J., van Herwaarden C.L., Folgering H.T., Gimeno A., and Dekhuijzen P.N. Xanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am. J. Physiol. 277 (1999) R1697-R1704
77. Uchida K., Shiraishi M., Naito Y., Torii Y., Nakamura Y., and Osawa T. Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J. Biol. Chem. 274 (1999) 2234-2242
78. Parola M., Bellomo G., Robino G., Barrera G., and Dianzani M.U. 4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. Antioxid. Redox Signal. 1 (1999) 255-284
79. Rahman I., Van Schadewijk A.A., Crowther A., Hiemstra P.S., Stolk J., MacNee W., et al. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am. J. Respir. Critit. Care Med. 166 (2002) 490-495
80. Harju T., Kaateenaho-Wiik R., Soini Y., Sormunen R., and Kinnula V.L. Diminished immunoreactivity of gamma-glutamylcysteine synthetase in the airways of smokers' lung. Am. J. Respir. Crit. Care Med. 166 (2002) 754-759
81. MacNee W. Oxidants/antioxidants and COPD. Chest 117 5 Suppl 1 (2000) 303S-317S
82. Langen R.C., Korn S.H., and Wouters E.F. ROS in the local and systemic pathogenesis of COPD. Free Radic. Biol. Med. 35 (2003) 226-235
83. Rahman I., Morrison D., Donaldson K., and MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am. J. Respir. Crit. Care Med. 154 (1996) 1055-1060
84. Koechlin C., Couillard A., Cristol J.P., Chanez P., Hayot M., Le Gallais D., et al. Does systemic inflammation trigger local exercise-induced oxidative stress in COPD?. Eur. Respir. J. 23 (2004) 538-544
85. Couillard A., Koechlin C., Cristol J.P., Varray A., and Préfaut C. Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients. Eur. Respir. J. 20 (2002) 1123-1129
86. Hageman G.J., Larik I., Pennings H.J., Haenen G.R., Wouters E.F., and Bast A. Systemic poly(ADP-ribose) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients. Free Radic. Biol. Med. 35 (2003) 140-148
87. Rahman I., Skwarska E., and MacNee W. Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease. Thorax 52 (1997) 565-568
88. Sahin U., Unlu M., Ozguner F., Sutcu R., Akkaya A., and Delibas N. Lipid peroxidation and glutathione peroxidase activity in chronic obstructive pulmonary disease exacerbation: prognostic value of malondialdehyde. J. Basic Clin. Physiol. Pharmacol. 12 (2001) 59-68
89. Pratico D., Basili S., Vieri M., Cordova C., Violi F., and Fitzgerald G.A. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. Am. J. Respir. Crit. Care Med. 158 (1998) 1709-1714
90. Koechlin C., Maltais F., Saey D., Michaud A., Leblanc P., Hayot M., et al. Hypoxemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary. Thorax 60 10 (2005) 834-841
91. Mercken E.M., Hageman G.J., Schols A.M., Akkermans M.A., Bast A., and Wouters E.F. Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 172 (2005) 994-1001
92. 2 therapy. J. Appl. Physiol. 81 (1996) 2198-2202
93. Couillard A., Maltais F., Saey D., Debigare R., Michaud A., Koechlin C., et al. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 167 (2003) 1664-1669
94. Van Helvoort H.A., Heijdra Y.F., Heunks L.M., Meijer P.L., Ruintenbeek W., Thijs H.M., et al. Supplemental oxygen prevents exercise-induced oxidative stress in muscle-wasted patients with chronic obstructibe pulmonary disease. Am. Respir. Crit. Care Med. 173 (2006) 1122-1129
95. Carpagnano G.E., Kharitonov S.A., Foschino-Barbaro M.P., Resta O., Gramiccioni E., and Barnes P.J. Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation. Thorax 59 (2004) 1016-1019
96. Foschino Barbaro M.P., Servidio G., Resta O., Rollo T., Tamborra R., Carpagnano G., et al. Oxygen therapy at low flow causes oxidative stress in chronic obstructive pulmonary disease: prevention by N-acetylcysteine. Free Radic. Res. 39 (2005) 1111-1118
97. Engelen M.P., Wouters E.F., Deutz N.E., Menheere P.P., and Schols A.M. Factors contributing to alterations in skeletal muscle and plasma amino acid profiles in patients with chronic obstructive pulmonary disease. Am. J. Clin. Nutr. 72 (2000) 1480-1487
98. Rabinovich R.A., Ardite E., Troosters T., Carbo N., Alonso J., Gonzalez de Suso J.M., et al. Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 164 (2001) 1114-1118
99. Gosker H.R., Bast A., Haenen G.R., Fischer M.A., Van der Vusse G.J., Wouters E.F., et al. Altered antioxidant status in peripheral skeletal muscle of patients with COPD. Respir. Med. 99 (2005) 118-125
100. Allaire J., Maltais F., LeBlanc P., Simard P.M., Whittom F., Doyon J.F., et al. Lipofuscin accumulation in the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Muscle Nerve 25 (2002) 383-389
101. Barreiro E., Gea J., Corominas J.M., and Hussain S.N. Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 29 (2003) 771-778
102. Koechlin C., Couillard A., Simar D., Cristol J.P., Bellet H., et al. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease?. Am. J. Respir. Crit. Care Med. 169 9 (2004) 1022-1027
103. Grievink L., Smit H.A., Ocke M.C., Van't Veer P., and Kromhout D. Dietary intake of antioxidant (pro)-vitamins, respiratory symptoms and pulmonary function: the MORGEN study. Thorax 53 (1998) 166-171
104. Smit H.A., Grievink L., and Tabak C. Dietary influences on chronic obstructive lung disease and asthma: a review of the epidemiological evidence. Proc. Nutr. Soc. 58 2 (1999) 309-319
105. Romieu I., and Trenga C. Diet and obstructive lung diseases. Epidemiol. Rev. 23 2 (2001) 268-287
106. Denny S.I., Thompson R.L., and Margetts B.M. Dietary factors in the pathogenesis of asthma and chronic obstructive pulmonary disease. Curr. Allergy Asthma Rep. 3 2 (2003) 130-136
107. Rautalahti M., Virtamo J., Haukka J., Heinonen O.P., Sundvall J., Albanes D., et al. The effect of alpha-tocopherol and beta-carotene supplementation on COPD symptoms. Am. J. Respir. Crit. Care Med. 156 5 (1997) 1447-1452
108. Tabak C., Arts I.C., Smit H.A., Heederik D., and Kromhout D. Chronic obstructive pulmonary disease and intake of catechins, flavonols, and flavones: the MORGEN Study. Am. J. Respir. Crit. Care Med. 164 1 (2001) 61-64
109. Walda I.C., Tabak C., Smit H.A., Rasanen L., Fidanza F., Menotti A., et al. Eur. J. Clin. Nutr. 56 (2002) 638-643
110. Daga M.K., Chhabra R., Sharma B., and Mishra T.K. Effects of exogenous vitamine E supplementation on the levels of oxidants and antioxidants in chronic obstructive pulmonary disease. J. Biosci. 28 1 (2003) 7-11
111. Agacdiken A., Basyigit I., Ozden M., Yildiz F., Ural D., Maral H., et al. The effects of antioxidants on exercise-induced lipid peroxidation in patients with COPD. Respirology 9 (2004) 38-42
112. Kelly G.S. Clinical applications of N-acetylcysteine. Altern. Med. Rev. 3 (1998) 114-127
113. Ziment I. Acetylcysteine: a drug that is much more than a mucokinetic. Biomed. Pharmacother. 42 (1988) 513-519
114. De Flora S., Bennicelli C., Camoirano A., Serra D., Romano M., Rossi G.A., et al. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds. Carcinogenesis 6 (1985) 1735-1745
115. Behr J., Maier K., Degenkolb B., Krombach F., and Vogelmeier C. Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression. Am. J. Respir. Crit. Care Med. 156 (1997) 1897-1901
116. De Vries N., and De Flora S. N-acetyl-l-cysteine. J. Cell. Biochem. Suppl. 17F (1993) 270-277
117. Aruoma O.I., Halliwell B., Hoey B.M., and Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic. Biol. Med. 6 (1989) 593-597
118. 2 toxicity by N-acetylcysteine. Eur. Respir. J. 2 (1989) 116-126
119. Bridgeman M.M., Marsden M., Selby C., Morrison D., and MacNee W. Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue. Thorax 49 (1994) 670-675
120. De Benetto F., Aceto A., Dragani B., Spacone A., Formisano S., Pela R., et al. Long-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD. Pulm. Pharmacol. Ther. 18 (2005) 41-47
121. Kasielski M., and Nowak D. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir. Med. 95 (2001) 448-456
122. Stey C., Steurer J., Bachmann S., Medici T.C., and Tramer M.R. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. Eur. Respir. J. 16 (2000) 253-262
123. Grandjean E.M., Berthet P., Ruffmann R., and Leuenberger P. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials. Clin. Ther. 22 (2000) 209-221
124. Lundbäck B., Lindström M., Andersson S., Nyström L., Rosenhall L., and Stejneberg N. Possible effects of acetylcysteine on lung function. Eur. Respir. J. 5 suppl. 15 (1992) 298S
125. Decramer M., Rutten-van Molken M., Dekhuijzen P.N., Troosters T., van Herwaarden C., Pellegrino R., et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomized placebo-controlled trial. Lancet 365 (2005) 1552-1560
126. Gillissen A., Jaworska M., Orth M., Coffiner M., Maes P., App E.M., et al. Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro. Respir. Med. 91 (1997) 159-168
127. Ekberg-Jansson A., Larson M., MacNee W., Tunek A., Wahlgren L., Wouters E.F.M., et al. N-isobutyrylcysteine, a donor of systemic thiols, does not reduce the exacerbation rate in chronic bronchitis. Eur. Respir. J. 13 (1999) 829-834
128. Young R.P., Hopkins R., Black P.N., Eddy C., Wu L., Gamble G.D., et al. Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function. Thorax 61 (2006) 394-399
129. Tuder R.M., Zhen L., Cho C.Y., Taraseviciene-Steward L., Kasahara Y., Salvemini D., et al. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am. J. Respir. Cell Mol. Biol. 29 (2003) 88-97
130. Fakhrzadeh L., Laskin J.D., Gardner C.R., and Laskin D.L. Superoxide dismutase-overexpressing mice are resistant to ozone-induced tissue injury and increases in nitric oxide and tumor necrosis factor-alpha. Am. J. Respir. Cell Mol. Biol. 30 (2004) 280-287
131. Haddad el B., McCluskie K., Birrell M.A., Dabrowski D., Pecoraro M., Underwood S., et al. Differential effects of ebselen on neutrophil recruitment, chemokine, and inflammatory mediator expression in a rat model of lipopolysaccharide-induced pulmonary inflammation. J. Immunol. 169 2 (2002) 974-982
132. Zhang M., Nomura A., Uchida Y., Iijima H., Sakamoto T., Iishii Y., et al. Ebselen suppresses late airway responses and airway inflammation in guinea pigs. Free Radic. Biol. Med. 32 5 (2002) 454-464
133. Martin A. Apports nutritionnels conseillés pour la population française CNERNA-Affsa (2001), Éditions Lavoisier Tec and Doc, Paris